Published in Vaccine Weekly, March 17th, 2004
Six volunteers were inoculated with the new vaccine at the Center for Vaccine Development, St. Louis University, Missouri, under the direction of Daniel F. Hoft. Volunteers are also being recruited at another trial site in Winston-Salem, North Carolina, by Piedmont Medical Research Associates under the direction of Thomas W. Littlejohn III.
The vaccine, known as rBCG30, was constructed by Marcus Horwitz and his research team at the David Geffen School of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.